RP-0217

N/A

Report date: 2025/01/26 17:50:34
NME

Base Information

Drug NameRP-0217
Drug Alias NameRP-0217
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAnnexin A1 modulators
TargetsAnnexin A1
Therapy Area/IndicationsOcular inflammationInflammationSexual Dysfunction, Physiological +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRe-Pharm Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRe-Pharm Ltd
Inactive CompaniesN/A
Active IndicationsOcular inflammationInflammationSexual Dysfunction, Physiological +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A